Literature DB >> 29800827

Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P2 position of PEXEL peptidomimetics.

William Nguyen1, Anthony N Hodder1, Richard Bestel de Lezongard1, Peter E Czabotar1, Kate E Jarman1, Matthew T O'Neill2, Jennifer K Thompson2, Helene Jousset Sabroux1, Alan F Cowman1, Justin A Boddey1, Brad E Sleebs3.   

Abstract

Plasmepsin V is an aspartyl protease that plays a critical role in the export of proteins bearing the Plasmodium export element (PEXEL) motif (RxLxQ/E/D) to the infected host erythrocyte, and thus the survival of the malaria parasite. Previously, development of transition state PEXEL mimetic inhibitors of plasmepsin V have primarily focused on demonstrating the importance of the P3 Arg and P1 Leu in binding affinity and selectivity. Here, we investigate the importance of the P2 position by incorporating both natural and non-natural amino acids into this position and show disubstituted beta-carbon amino acids convey the greatest potency. Consequently, we show analogues with either cyclohexylglycine or phenylglycine in the P2 position are the most potent inhibitors of plasmepsin V that impair processing of the PEXEL motif in exported proteins resulting in death of P. falciparum asexual stage parasites.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Malaria; PEXEL; Peptidomimetic; Plasmepsin; Protease; Trafficking

Mesh:

Substances:

Year:  2018        PMID: 29800827     DOI: 10.1016/j.ejmech.2018.05.022

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  In Silico and In Vitro Antimalarial Screening and Validation Targeting Plasmodium falciparum Plasmepsin V.

Authors:  Xin Ji; Zhensheng Wang; Qianqian Chen; Jingzhong Li; Heng Wang; Zenglei Wang; Lan Yang
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

2.  Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle.

Authors:  Paola Favuzza; Manuel de Lera Ruiz; Jennifer K Thompson; Tony Triglia; Anna Ngo; Ryan W J Steel; Marissa Vavrek; Janni Christensen; Julie Healer; Christopher Boyce; Zhuyan Guo; Mengwei Hu; Tanweer Khan; Nicholas Murgolo; Lianyun Zhao; Jocelyn Sietsma Penington; Kitsanapong Reaksudsan; Kate Jarman; Melanie H Dietrich; Lachlan Richardson; Kai-Yuan Guo; Sash Lopaticki; Wai-Hong Tham; Matthias Rottmann; Tony Papenfuss; Jonathan A Robbins; Justin A Boddey; Brad E Sleebs; Hélène Jousset Sabroux; John A McCauley; David B Olsen; Alan F Cowman
Journal:  Cell Host Microbe       Date:  2020-02-27       Impact factor: 21.023

3.  Flap Dynamics in Pepsin-Like Aspartic Proteases: A Computational Perspective Using Plasmepsin-II and BACE-1 as Model Systems.

Authors:  Soumendranath Bhakat; Pär Söderhjelm
Journal:  J Chem Inf Model       Date:  2022-02-09       Impact factor: 4.956

4.  The Medicines for Malaria Venture Malaria Box contains inhibitors of protein secretion in Plasmodium falciparum blood stage parasites.

Authors:  Oliver Looker; Madeline G Dans; Hayley E Bullen; Brad E Sleebs; Brendan S Crabb; Paul R Gilson
Journal:  Traffic       Date:  2022-08-15       Impact factor: 6.144

Review 5.  Protease Inhibition-An Established Strategy to Combat Infectious Diseases.

Authors:  Daniel Sojka; Pavla Šnebergerová; Luïse Robbertse
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.